hcci genesis bradhurst housing development fund corporation

2854 frederick douglass blvd
new york, new york, 10039

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 24, 2013

NYS DOS ID#
4421957

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2013 - HCCI GENESIS BRADHURST HOUSING DEVELOPMENT FUND CORPORATION









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Trump Family Wedding Planner to Head New York’s Federal Housing Office
    By YAMICHE ALCINDOR and J. DAVID GOODMAN - Friday Jun 16, 2017

    The appointment of Lynne Patton, who planned Eric Trump’s wedding, to head the Department of Housing and Urban Development’s New York office, is raising eyebrows.

    Source: NYT > Home Page
  • ‘I’d Be Hurt and Upset’: Cities Fear Trump’s Cuts to Urban Programs
    By YAMICHE ALCINDOR - Friday Mar 17, 2017

    President Trump’s proposed cuts to the Department of Housing and Urban Development would eliminate programs cities have used to fund things like Meals on Wheels.

    Source: New York Times
  • Greater Minnesota Housing Fund Launches Impact Investment Fund
    By webmaster@philanthropynewsdigest.org (Matt Sinclair) - Thursday Jun 8, 2017

    A public-private partnership, the new fund will support efforts to acquire and preserve affordable housing in the Twin Cities....

    Source: Philanthropy News Digest (PND)
  • Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More
    By Alex Lash - Friday Jun 9, 2017

    The New York Times Magazine wrote a few weeks ago about the extraordinary metabolic changes in a python after it gulps down a 50,000 calorie meal. The biomedical world was like a postprandial python this week; after extending its maw around the supersized meal of news and data from the American Society for Clinical Oncology […]

    Source: Xconomy New York
  • Athenex IPO Raises $66M to Fund Clinical Trials for Cancer Drugs
    By Frank Vinluan - Wednesday Jun 14, 2017

    The IPO window is still open for clinical-stage drug companies, and Athenex is now the latest one to pass through it. The cancer drug developer raised $66 million through a public stock offering on Wednesday, funding that the company will devote mostly to a pair of cancer drugs in late-stage clinical development. Athenex priced its […]

    Source: Xconomy New York
  • Five Sites of New York’s L.G.B.T. History
    Monday Jun 19, 2017

    Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.

    Source: NYT > Home Page
  • Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
    By LIAM STACK - Monday Jun 19, 2017

    The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.

    Source: NYT > Home Page
  • Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
    By Frank Vinluan - Tuesday May 30, 2017

    Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]

    Source: Xconomy New York